Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Patent and Innovation Trends in GLP-1 and Weight Loss Drugs (20202025): What the IP and Science Signal Next This article was powered by Cypris Q, an AI agent that helps R&D teams instantly synthesize insights from patents, scientific literature, and market intelligence from around the globe
Each consignment is signed for on delivery and traceable end-to-end through the Royal Mail reference supplied at dispatch
Many patients with metabolic syndrome have normal LDL but severely elevated triglycerides
Medications include osmotic laxatives, stimulant laxatives, and other agents
10.1042/bj20111451 31 LenardoM
US$ 21.55
US$ 24.14
US$ 25.88
US$ 28.70
